{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:22:25Z","timestamp":1790245345409,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The importance of ACF is not fully explained, however, their number may be a good predictor of synchronous and metachronic adenoma or other polyps whose removal reduces the risk of CRC. Due to the epidemiological and genetic association of ACF with pre-cancer lesions, they may be a potential CRC biomarker. The aim of our study was to show that the number and type of rectal ACF may be a good predictive factor for the presence of polyps located proximally from the splenic flexure and that the type and number of ACF can correlate with the number and specific types of polyps in the large intestine.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The study included 131 patients who underwent colonoscopy combined with rectal mucosa staining with 0.25% methylene blue. The number of rectal ACF was determined and bioptats were sampled for histopathological examination to assess the type of ACF. Endoscopic ACF assessment criteria given by L. Roncucci were used. The obtained material was subjected to statistical analysis using probability distribution, U-test, t-student test, and chi <jats:sup>2<\/jats:sup> as well as the Statistica 7.1 software package.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The study population was divided into three subgroups according to the number of ACF observed, i.e. ACF\u2009&lt;\u20095, 5\u201310 and\u2009&gt;\u200910. ACF\u2009&lt;\u20095 were found in 35 patients (29.41%), 5\u201310 ACF in 70 (58.82%) and ACF\u2009&gt;\u200910 in 14 individuals (11.76%).<\/jats:p>\n<jats:p>The study revealed the presence of normal ACF (<jats:italic>p<\/jats:italic>\u2009=\u20090.49), hyperplastic ACF (<jats:italic>p<\/jats:italic>\u2009=\u20090.34), dysplastic ACF (<jats:italic>p<\/jats:italic>\u2009=\u20090.11), and mixed ACF (<jats:italic>p<\/jats:italic>\u2009=\u20090.06). A single type of ACF was most commonly observed (<jats:italic>n<\/jats:italic>\u2009=\u200988, <jats:italic>p<\/jats:italic>\u2009=\u20090.74). In the researched group a larger number of ACF is concurrent with adenomas and hyperplastic polyps. The number of ACF clearly correlates with the dysplasia advancement in the adenoma and the number of polyps found.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Rectal ACF are a useful marker for the presence of cancerous lesions in the proximal and distal sections of the large intestine.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-020-6590-4","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T12:03:52Z","timestamp":1582113832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine"],"prefix":"10.1186","volume":"20","author":[{"given":"Marek","family":"Kowalczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Or\u0142owski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Klepacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Zinkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar","family":"Kurpiewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Kaczerska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wies\u0142aw","family":"Pesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-6448","authenticated-orcid":false,"given":"Ewa","family":"Zieli\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Siermontowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,19]]},"reference":[{"key":"6590_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1046\/j.1365-2559.2000.01028.x","volume":"37","author":"JR Jass","year":"2000","unstructured":"Jass JR, Young J, Leggett BA. Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum. Histopathology. 2000;37:295\u2013301.","journal-title":"Histopathology"},{"issue":"17","key":"6590_CR2","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/jnci\/93.17.1282","volume":"93","author":"SR Hamilton","year":"2001","unstructured":"Hamilton SR. Origin of colorectal cancers in hyperplastic polyps and serrated adenomas: another truism bites the dust. J Natl Cancer Inst. 2001;93(17):1282\u20133.","journal-title":"J Natl Cancer Inst"},{"key":"6590_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/gut.47.1.43","volume":"47","author":"JR Jass","year":"2000","unstructured":"Jass JR, Iino H, Ruszkiewicz A, et al. Neoplastic progression occurs through mutator pathway in hyperplastic polyposis of the colorectum. Gut. 2000;47:43\u20139.","journal-title":"Gut"},{"key":"6590_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1158\/1541-7786.MCR-06-0398","volume":"5","author":"WS Samowitz","year":"2007","unstructured":"Samowitz WS, Slattery ML, Sweeney C, et al. APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res. 2007;5:165\u201370.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"6590_CR5","doi-asserted-by":"publisher","first-page":"e0148286","DOI":"10.1371\/journal.pone.0148286","volume":"11","author":"M Kowalczyk","year":"2016","unstructured":"Kowalczyk M, Siermontowski P, Mucha D, et al. Chromoendoscopy with a standard- resolution Colonoscope for evaluation of rectal aberrant crypt foci. PLoS One. 2016;11(2):e0148286.","journal-title":"PLoS One"},{"key":"6590_CR6","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJM199810293391803","volume":"339","author":"T Takayama","year":"1998","unstructured":"Takayama T, Katsuki S, Takahashi Y, et al. Aberrant crypt foci of the colon as the precursor of adenoma and cancer. N Engl J Med. 1998;339:1277\u201384.","journal-title":"N Engl J Med"},{"key":"6590_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cancergencyto.2006.11.001","volume":"174","author":"BM Brenner","year":"2007","unstructured":"Brenner BM, Stoler DL, Rodriguez L, et al. Allelic losses at genomic instability-associated loci in villous adenomas and adjacent colorectal cancers. Cancer Genet Cytogenet. 2007;174:9\u201315.","journal-title":"Cancer Genet Cytogenet"},{"key":"6590_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0046-8177(91)90163-J","volume":"22","author":"L Roncucci","year":"1991","unstructured":"Roncucci L, Stamp D, Medline AA, et al. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol. 1991;22:287\u201394.","journal-title":"Hum Pathol"},{"issue":"5","key":"6590_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1443-1661.2012.01289.x","volume":"24","author":"T Uchiyama","year":"2012","unstructured":"Uchiyama T, Takahashi H, Endo H, et al. Number of aberrant crypt foci in the rectum is a useful surrogate marker of colorectal adenoma recurrence. Dig Endosc. 2012;24(5):353\u20137.","journal-title":"Dig Endosc"},{"issue":"9","key":"6590_CR10","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1158\/1055-9965.EPI-11-0104","volume":"20","author":"E Sakai","year":"2011","unstructured":"Sakai E, Takahashi H, Kato S, et al. Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm. Cancer Epidemiol Biomark Prev. 2011;20(9):1918\u201324.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"6590_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00384-008-0576-z","volume":"24","author":"P Figueiredo","year":"2009","unstructured":"Figueiredo P, Donato M, Urbano M, et al. Aberrant crypt foci: endoscopic assessment and cell kinetics characterization. Int J Color Dis. 2009;24(4):441\u201350.","journal-title":"Int J Color Dis"},{"key":"6590_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12885-018-4100-8","volume":"18","author":"M Kowalczyk","year":"2018","unstructured":"Kowalczyk M, Or\u0142owski M, Siermontowski P, et al. Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients. BMC Cancer. 2018;18:213.","journal-title":"BMC Cancer"},{"issue":"12","key":"6590_CR13","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.3748\/wjg.v9.i12.2642","volume":"9","author":"L Cheng","year":"2003","unstructured":"Cheng L, Lai MD. Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol. 2003;9(12):2642\u20139.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"6590_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/jso.21106","volume":"98","author":"FA Orlando","year":"2008","unstructured":"Orlando FA, Tan D, Baltodano JD. Aberrant Crypt Foci as Precursors in Colorectal Cancer Progression. J Surg Oncol. 2008;98(3):207\u201313.","journal-title":"J Surg Oncol"},{"key":"6590_CR15","first-page":"1271","volume":"9","author":"WR Bruce","year":"2000","unstructured":"Bruce WR, Garcia A. Medline a possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomark Prev. 2000;9:1271\u20139.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"6590_CR16","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/00000478-199910000-00011","volume":"23","author":"R Nascimbeni","year":"1999","unstructured":"Nascimbeni R, Villanacci V, Mariani PP, et al. Aberrant crypt foci in the human colon: frequency and histologic patterns in patients with colorectal cancer or diverticular disease. Am J Surg Pathol. 1999;23:1256\u201363.","journal-title":"Am J Surg Pathol"},{"key":"6590_CR17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0016-5107(02)70113-2","volume":"56","author":"DG Adler","year":"2002","unstructured":"Adler DG, Gostout CJ, Sorbi D, et al. Endoscopic identification and quantification of aberrant crypt foci in the human colon. Gastrointest Endosc. 2002;56:657\u201362.","journal-title":"Gastrointest Endosc"},{"key":"6590_CR18","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1158\/1055-9965.EPI-04-0058","volume":"14","author":"RE Rudolph","year":"2005","unstructured":"Rudolph RE, Dominitz JA, Lampe JW, et al. Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans. Cancer Epidemiol Biomarkers Prev. 2005;14:605\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"6590_CR19","first-page":"1805","volume":"150","author":"S I-Mei","year":"1997","unstructured":"I-Mei S, Pretlow TG, Amini SB, et al. Identification of dysplasia in human colonic aberrant crypt foci. Am J Pathol. 1997;150(5):1805\u201313.","journal-title":"Am J Pathol"},{"key":"6590_CR20","first-page":"4743","volume":"55","author":"K Otori","year":"1995","unstructured":"Otori K, Sugiyama K, Hasebe T, et al. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation. Cancer Res. 1995;55:4743\u20136.","journal-title":"Cancer Res"},{"issue":"12","key":"6590_CR21","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1038\/bjc.1998.389","volume":"77","author":"L Roncucci","year":"1998","unstructured":"Roncucci L, Modica S, Pedroni M, et al. Aberrant crypt foci in patients with colorectal cancer. Br J Cancer. 1998;77(12):2343\u20138.","journal-title":"Br J Cancer"},{"key":"6590_CR22","first-page":"111","volume":"2","author":"J Or\u0142owska","year":"2009","unstructured":"Or\u0142owska J, Kiedrowski M. Serrated adenomas, hyperplastic polyposis and carcinoma of the colorectum. Borgis \u2013 Post\u0119py Nauk Medycznych. 2009;2:111\u20137.","journal-title":"Borgis \u2013 Post\u0119py Nauk Medycznych"},{"key":"6590_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0046-8177(98)90062-4","volume":"29","author":"B Shpitz","year":"1998","unstructured":"Shpitz B, Bomstein Y, Mekori Y, et al. Aberrant crypt foci in human colons: distribution and histomorphologic characteristics. Hum Pathol. 1998;29:469\u201375.","journal-title":"Hum Pathol"},{"key":"6590_CR24","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/j.1572-0241.2006.00578.x","volume":"101","author":"K Seike","year":"2006","unstructured":"Seike K, Koda K, Oda K, et al. Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value for colonic advanced neoplasm. Am J Gastroenterol. 2006;101:1362\u20139.","journal-title":"Am J Gastroenterol"},{"key":"6590_CR25","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/j.1572-0241.2005.40891.x","volume":"100","author":"DP Hurlston","year":"2005","unstructured":"Hurlston DP, Karajeh M, Sanders DS, et al. Ractal aberrant crypt foci identified using high-magnification-chromoscopiccolonoscopy:biomarkers for flat and depressed neoplasia. Am J Gastroenterol. 2005;100:1283\u20139.","journal-title":"Am J Gastroenterol"},{"key":"6590_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0046-8177(99)90302-7","volume":"30","author":"H Bouzourene","year":"1999","unstructured":"Bouzourene H, Chaubert P, Seelentag W, et al. Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic disease. Hum Pathol. 1999;30:66\u201371.","journal-title":"Hum Pathol"},{"issue":"2","key":"6590_CR27","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.canlet.2006.08.003","volume":"248","author":"RG Stevens","year":"2006","unstructured":"Stevens RG, Swede H, Heinen CD, et al. Aberrant crypt foci in patents with a positive family history of sporadic colorectal cancer. Cancer Lett. 2006;248(2):262\u20138.","journal-title":"Cancer Lett"},{"key":"6590_CR28","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/S0046-8177(97)90230-6","volume":"28","author":"MR Nucci","year":"1997","unstructured":"Nucci MR, Robinson CR, Longo P. Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum Pathol. 1997;28:1396\u2013407.","journal-title":"Hum Pathol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6590-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-6590-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6590-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T05:49:26Z","timestamp":1613800166000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-6590-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,19]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6590"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-6590-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,19]]},"assertion":[{"value":"23 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients gave oral consent, then gave written consent for participation, in addition, the authors received Approval for research issued by Bioethical Commission at the Faculty of Medical Sciences of the University of Warmia and Mazuria in Olsztyn.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}